* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 5159 | PDGFRB | C0432284 | Infantile myofibromatosis | 0.401098907136852 | BEFREE;ORPHANET;UNIPROT |
| 5159 | PDGFRB | C1851585 | MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA | 0.4 | CTD_human;HPO |
| 5159 | PDGFRB | C1866182 | Penttinen-Aula syndrome | 0.4 | ORPHANET;UNIPROT |
| 5159 | PDGFRB | C0027022 | Myeloproliferative disease | 0.213693273078703 | BEFREE;HPO;LHGDN |
| 5159 | PDGFRB | C0014457 | Eosinophilia | 0.204945082115836 | BEFREE;HPO |
| 5159 | PDGFRB | C0023480 | Leukemia, Myelomonocytic, Chronic | 0.201373633921065 | BEFREE;ORPHANET |
| 5159 | PDGFRB | C0036341 | Schizophrenia | 0.200549453568426 | BEFREE;PSYGENET |
| 5159 | PDGFRB | C0014544 | Epilepsy | 0.200274726784213 | BEFREE;HPO |
| 5159 | PDGFRB | C0033975 | Psychotic Disorders | 0.200274726784213 | BEFREE;HPO |
| 5159 | PDGFRB | C0036337 | Schizoaffective Disorder | 0.200274726784213 | BEFREE;PSYGENET |
| 5159 | PDGFRB | C0036572 | Seizures | 0.200274726784213 | BEFREE;HPO |
| 5159 | PDGFRB | C0393590 | Fahr's syndrome (disorder) | 0.200274726784213 | BEFREE;ORPHANET |
| 5159 | PDGFRB | C0575081 | Gait abnormality | 0.2 | HPO |
| 5159 | PDGFRB | C0576225 | Long foot | 0.2 | HPO |
| 5159 | PDGFRB | C0578038 | Thin lips | 0.2 | HPO |
| 5159 | PDGFRB | C0586553 | Raised TSH level | 0.2 | HPO |
| 5159 | PDGFRB | C0746926 | Multiple, subcutaneous nodules | 0.2 | HPO |
| 5159 | PDGFRB | C0747078 | Generalized osteopenia | 0.2 | HPO |
| 5159 | PDGFRB | C0749379 | Thoracolumbar scoliosis | 0.2 | HPO |
| 5159 | PDGFRB | C0751295 | Memory Loss | 0.2 | HPO |
| 5159 | PDGFRB | C0854107 | Haemorrhage subcutaneous | 0.2 | HPO |
| 5159 | PDGFRB | C0870082 | Hyperkeratosis | 0.2 | HPO |
| 5159 | PDGFRB | C0917990 | Acro-Osteolysis | 0.2 | HPO |
| 5159 | PDGFRB | C1280433 | Lipoatrophy | 0.2 | HPO |
| 5159 | PDGFRB | C1386048 | Intrauterine retardation | 0.2 | HPO |
| 5159 | PDGFRB | C1389280 | Basal ganglia calcification | 0.2 | HPO |
| 5159 | PDGFRB | C1833144 | Slender, gracile long tubular bones | 0.2 | HPO |
| 5159 | PDGFRB | C1837249 | Malformations of Cortical Development, Group II | 0.2 | HPO |
| 5159 | PDGFRB | C1837260 | Prominent forehead | 0.2 | HPO |
| 5159 | PDGFRB | C1837760 | Prominent eyes | 0.2 | HPO |
| 5159 | PDGFRB | C1837770 | Sparse hair | 0.2 | HPO |
| 5159 | PDGFRB | C1839764 | Broad flat nasal bridge | 0.2 | HPO |
| 5159 | PDGFRB | C1842060 | Prominent supraorbital ridges | 0.2 | HPO |
| 5159 | PDGFRB | C1843921 | Postural instability | 0.2 | HPO |
| 5159 | PDGFRB | C1844505 | Pointed chin | 0.2 | HPO |
| 5159 | PDGFRB | C1848490 | Protruding eyes | 0.2 | HPO |
| 5159 | PDGFRB | C0004158 | Athetosis | 0.2 | HPO |
| 5159 | PDGFRB | C1849265 | Overgrowth | 0.2 | HPO |
| 5159 | PDGFRB | C1849367 | Nasal bridge wide | 0.2 | HPO |
| 5159 | PDGFRB | C0004782 | Basal Ganglia Diseases | 0.2 | CTD_human |
| 5159 | PDGFRB | C1851731 | Generalized overgrowth | 0.2 | HPO |
| 5159 | PDGFRB | C0005745 | Blepharoptosis | 0.2 | HPO |
| 5159 | PDGFRB | C1853242 | Midface retrusion | 0.2 | HPO |
| 5159 | PDGFRB | C0005937 | Bone Cysts | 0.2 | HPO |
| 5159 | PDGFRB | C1853562 | Adult onset | 0.2 | HPO |
| 5159 | PDGFRB | C1854489 | Limb dysmetria | 0.2 | HPO |
| 5159 | PDGFRB | C1854838 | Progressive neurologic deterioration | 0.2 | HPO |
| 5159 | PDGFRB | C0006663 | Calcinosis | 0.2 | CTD_human |
| 5159 | PDGFRB | C1856231 | Thin calvarium | 0.2 | HPO |
| 5159 | PDGFRB | C1857130 | Hypoplastic mandible condyle | 0.2 | HPO |
| 5159 | PDGFRB | C1859273 | Dense calcifications in the cerebellar dentate nucleus | 0.2 | HPO |
| 5159 | PDGFRB | C1860844 | Thin, sparse hair | 0.2 | HPO |
| 5159 | PDGFRB | C1862425 | Prominent globes | 0.2 | HPO |
| 5159 | PDGFRB | C0007114 | Malignant neoplasm of skin | 0.2 | HPO |
| 5159 | PDGFRB | C1864985 | Progressive disorder | 0.2 | HPO |
| 5159 | PDGFRB | C1865017 | Thin upper lip vermilion | 0.2 | HPO |
| 5159 | PDGFRB | C1867446 | Bulging forehead | 0.2 | HPO |
| 5159 | PDGFRB | C0008489 | Chorea | 0.2 | HPO |
| 5159 | PDGFRB | C2673410 | Small midface | 0.2 | HPO |
| 5159 | PDGFRB | C2677869 | Hair shaft abnormalities | 0.2 | HPO |
| 5159 | PDGFRB | C0010038 | Corneal Opacity | 0.2 | HPO |
| 5159 | PDGFRB | C3150281 | Fetal overgrowth | 0.2 | HPO |
| 5159 | PDGFRB | C0011581 | Depressive disorder | 0.2 | HPO |
| 5159 | PDGFRB | C3278923 | Dilated ventricles (finding) | 0.2 | HPO |
| 5159 | PDGFRB | C0013362 | Dysarthria | 0.2 | HPO |
| 5159 | PDGFRB | C3472621 | Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement | 0.2 | ORPHANET |
| 5159 | PDGFRB | C0013421 | Dystonia | 0.2 | HPO |
| 5159 | PDGFRB | C3554321 | BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4 | 0.2 | UNIPROT |
| 5159 | PDGFRB | C0015300 | Exophthalmos | 0.2 | HPO |
| 5159 | PDGFRB | C0015934 | Fetal Growth Retardation | 0.2 | HPO |
| 5159 | PDGFRB | C4020858 | Choreatic disease | 0.2 | HPO |
| 5159 | PDGFRB | C0016045 | fibroma | 0.2 | HPO |
| 5159 | PDGFRB | C4020871 | Dystonic disease | 0.2 | HPO |
| 5159 | PDGFRB | C0016049 | Fibromatosis, Gingival | 0.2 | HPO |
| 5159 | PDGFRB | C4021745 | Abnormality of the musculature | 0.2 | HPO |
| 5159 | PDGFRB | C4021797 | Abnormality of the thorax | 0.2 | HPO |
| 5159 | PDGFRB | C4025596 | Abnormality of connective tissue | 0.2 | HPO |
| 5159 | PDGFRB | C4025703 | Calcification of the small brain vessels | 0.2 | HPO |
| 5159 | PDGFRB | C4025814 | Abnormality of the metaphyses | 0.2 | HPO |
| 5159 | PDGFRB | C0018784 | Sensorineural Hearing Loss (disorder) | 0.2 | HPO |
| 5159 | PDGFRB | C4225270 | KOSAKI OVERGROWTH SYNDROME | 0.2 | UNIPROT |
| 5159 | PDGFRB | C0019209 | Hepatomegaly | 0.2 | HPO |
| 5159 | PDGFRB | C4280320 | Hypotrophic midface | 0.2 | HPO |
| 5159 | PDGFRB | C0020490 | Hyperopia | 0.2 | HPO |
| 5159 | PDGFRB | C4280321 | Decreased projection of midface | 0.2 | HPO |
| 5159 | PDGFRB | C4280379 | Thin skull bone | 0.2 | HPO |
| 5159 | PDGFRB | C4280577 | Uncoordinated limb movement | 0.2 | HPO |
| 5159 | PDGFRB | C0021296 | Infant, Small for Gestational Age | 0.2 | HPO |
| 5159 | PDGFRB | C4280636 | Hypertrophy of supraorbital ridge | 0.2 | HPO |
| 5159 | PDGFRB | C4280637 | Hypertrophy of supraorbital margins | 0.2 | HPO |
| 5159 | PDGFRB | C4280638 | Hyperplasia of supraorbital ridge | 0.2 | HPO |
| 5159 | PDGFRB | C4280639 | Hyperplasia of supraorbital margins | 0.2 | HPO |
| 5159 | PDGFRB | C4280677 | Idiopathic gingival hyperplasia | 0.2 | HPO |
| 5159 | PDGFRB | C0023893 | Liver Cirrhosis, Experimental | 0.2 | CTD_human |
| 5159 | PDGFRB | C0024121 | Lung Neoplasms | 0.2 | HPO |
| 5159 | PDGFRB | C0025990 | Micrognathism | 0.2 | HPO |
| 5159 | PDGFRB | C0026837 | Muscle Rigidity | 0.2 | HPO |
| 5159 | PDGFRB | C0029453 | Osteopenia | 0.2 | HPO |
| 5159 | PDGFRB | C0037286 | Skin Neoplasms | 0.2 | HPO |
| 5159 | PDGFRB | C0040034 | Thrombocytopenia | 0.2 | HPO |
| 5159 | PDGFRB | C0040822 | Tremor | 0.2 | HPO |
| 5159 | PDGFRB | C0042024 | Urinary Incontinence | 0.2 | HPO |
| 5159 | PDGFRB | C0151811 | Subcutaneous nodule | 0.2 | HPO |
| 5159 | PDGFRB | C0151889 | Hyperreflexia | 0.2 | HPO |
| 5159 | PDGFRB | C0157733 | hair abnormalities (non-specific) | 0.2 | HPO |
| 5159 | PDGFRB | C0221357 | Brachydactyly | 0.2 | HPO |
| 5159 | PDGFRB | C0233565 | Bradykinesia | 0.2 | HPO |
| 5159 | PDGFRB | C0233794 | Memory impairment | 0.2 | HPO |
| 5159 | PDGFRB | C0234979 | Dysdiadochokinesis | 0.2 | HPO |
| 5159 | PDGFRB | C0234985 | Mental deterioration | 0.2 | HPO |
| 5159 | PDGFRB | C0235942 | Skull malformation | 0.2 | HPO |
| 5159 | PDGFRB | C0239174 | Late tooth eruption | 0.2 | HPO |
| 5159 | PDGFRB | C0240295 | Mandibular hypoplasia | 0.2 | HPO |
| 5159 | PDGFRB | C0241074 | Skin hyperelastic | 0.2 | HPO |
| 5159 | PDGFRB | C0241181 | Fragile skin | 0.2 | HPO |
| 5159 | PDGFRB | C0242422 | Parkinsonian Disorders | 0.2 | HPO |
| 5159 | PDGFRB | C0262361 | abnormal growth | 0.2 | HPO |
| 5159 | PDGFRB | C0270685 | Cerebral calcification | 0.2 | HPO |
| 5159 | PDGFRB | C0277828 | Late fontanel closure | 0.2 | HPO |
| 5159 | PDGFRB | C0392386 | Decreased platelet count | 0.2 | HPO |
| 5159 | PDGFRB | C0399440 | Hereditary gingival fibromatosis | 0.2 | HPO |
| 5159 | PDGFRB | C0423110 | Downward slant of palpebral fissure | 0.2 | HPO |
| 5159 | PDGFRB | C0423757 | Thin skin | 0.2 | HPO |
| 5159 | PDGFRB | C0424448 | Mask-like facies | 0.2 | HPO |
| 5159 | PDGFRB | C0424688 | Small head | 0.2 | HPO |
| 5159 | PDGFRB | C0426422 | Narrow nose | 0.2 | HPO |
| 5159 | PDGFRB | C0521719 | Clouding of corneal stroma | 0.2 | HPO |
| 5159 | PDGFRB | C0541764 | Delayed bone age | 0.2 | HPO |
| 5159 | PDGFRB | C0542476 | Forgetful | 0.2 | HPO |
| 5159 | PDGFRB | C0553730 | Calcium pyrophosphate deposition disease | 0.2 | HPO |
| 5159 | PDGFRB | C0020538 | Hypertensive disease | 0.0805494535684262 | BEFREE;RGD |
| 5159 | PDGFRB | C0740392 | Infarction, Middle Cerebral Artery | 0.08 | RGD |
| 5159 | PDGFRB | C2936380 | Neointima | 0.08 | RGD |
| 5159 | PDGFRB | C0014072 | Experimental Autoimmune Encephalomyelitis | 0.08 | RGD |
| 5159 | PDGFRB | C0149940 | Sciatic Neuropathy | 0.08 | RGD |
| 5159 | PDGFRB | C0017638 | Glioma | 0.0073889124191192 | BEFREE;LHGDN |
| 5159 | PDGFRB | C0033578 | Prostatic Neoplasms | 0.0057405517138406 | BEFREE;LHGDN |
| 5159 | PDGFRB | C1292778 | Chronic myeloproliferative disorder | 0.0049450821158358 | BEFREE |
| 5159 | PDGFRB | C1306759 | Eosinophilic disorder | 0.0046703553316227 | BEFREE |
| 5159 | PDGFRB | C0017636 | Glioblastoma | 0.0035714481947703 | BEFREE |
| 5159 | PDGFRB | C0027809 | Neurilemmoma | 0.00355709281745305 | BEFREE;LHGDN |
| 5159 | PDGFRB | C0919267 | ovarian neoplasm | 0.00300763924902685 | BEFREE;LHGDN |
| 5159 | PDGFRB | C1261473 | Sarcoma | 0.00300763924902685 | BEFREE;LHGDN |
| 5159 | PDGFRB | C0206647 | Dermatofibrosarcoma | 0.00300763924902685 | BEFREE;LHGDN |
| 5159 | PDGFRB | C0007095 | Carcinoid Tumor | 0.00273291246481375 | LHGDN |
| 5159 | PDGFRB | C0009404 | Colorectal Neoplasms | 0.00273291246481375 | LHGDN |
| 5159 | PDGFRB | C0016059 | Fibrosis | 0.00273291246481375 | LHGDN |
| 5159 | PDGFRB | C0021368 | Inflammation | 0.00273291246481375 | LHGDN |
| 5159 | PDGFRB | C0028326 | Noonan Syndrome | 0.00273291246481375 | LHGDN |
| 5159 | PDGFRB | C0034885 | Rectal Neoplasms | 0.00273291246481375 | LHGDN |
| 5159 | PDGFRB | C0039101 | synovial sarcoma | 0.00273291246481375 | LHGDN |
| 5159 | PDGFRB | C0206630 | Endometrial Stromal Sarcoma | 0.00273291246481375 | LHGDN |
| 5159 | PDGFRB | C1140680 | Malignant neoplasm of ovary | 0.0026817553075011 | BEFREE;GAD |
| 5159 | PDGFRB | C0002395 | Alzheimer's Disease | 0.0026817553075011 | BEFREE;GAD |
| 5159 | PDGFRB | C0238198 | Gastrointestinal Stromal Tumors | 0.0024725410579179 | BEFREE |
| 5159 | PDGFRB | C0020503 | Hyperparathyroidism, Secondary | 0.002407028523288 | GAD |
| 5159 | PDGFRB | C0023434 | Chronic Lymphocytic Leukemia | 0.002407028523288 | GAD |
| 5159 | PDGFRB | C0023470 | Myeloid Leukemia | 0.002407028523288 | GAD |
| 5159 | PDGFRB | C0600139 | Prostate carcinoma | 0.0016483607052786 | BEFREE |
| 5159 | PDGFRB | C3693482 | Giant Cell Fibroblastoma | 0.0016483607052786 | BEFREE |
| 5159 | PDGFRB | C0027627 | Neoplasm Metastasis | 0.0016483607052786 | BEFREE |
| 5159 | PDGFRB | C0376358 | Malignant neoplasm of prostate | 0.0016483607052786 | BEFREE |
| 5159 | PDGFRB | C0392784 | Dermatofibrosarcoma Protuberans | 0.0016483607052786 | BEFREE |
| 5159 | PDGFRB | C1621958 | Glioblastoma Multiforme | 0.0013736339210655 | BEFREE |
| 5159 | PDGFRB | C0009402 | Colorectal Carcinoma | 0.0013736339210655 | BEFREE |
| 5159 | PDGFRB | C0025202 | melanoma | 0.0013736339210655 | BEFREE |
| 5159 | PDGFRB | C1527249 | Colorectal Cancer | 0.0010989071368524 | BEFREE |
| 5159 | PDGFRB | C0346421 | Chronic eosinophilic leukemia | 0.0010989071368524 | BEFREE |
| 5159 | PDGFRB | C0678222 | Breast Carcinoma | 0.0008241803526393 | BEFREE |
| 5159 | PDGFRB | C1292772 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 0.0008241803526393 | BEFREE |
| 5159 | PDGFRB | C0006142 | Malignant neoplasm of breast | 0.0008241803526393 | BEFREE |
| 5159 | PDGFRB | C0007131 | Non-Small Cell Lung Carcinoma | 0.0008241803526393 | BEFREE |
| 5159 | PDGFRB | C2239176 | Liver carcinoma | 0.0008241803526393 | BEFREE |
| 5159 | PDGFRB | C0023418 | leukemia | 0.0008241803526393 | BEFREE |
| 5159 | PDGFRB | C0025149 | Medulloblastoma | 0.0008241803526393 | BEFREE |
| 5159 | PDGFRB | C0206141 | Idiopathic Hypereosinophilic Syndrome | 0.0008241803526393 | BEFREE |
| 5159 | PDGFRB | C0206648 | Myofibromatosis | 0.0008241803526393 | BEFREE |
| 5159 | PDGFRB | C0596263 | Carcinogenesis | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0677932 | Progressive Neoplastic Disease | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0699885 | Carcinoma of bladder | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0700095 | Central neuroblastoma | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0005684 | Malignant neoplasm of urinary bladder | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0005695 | Bladder Neoplasm | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0006118 | Brain Neoplasms | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0007134 | Renal Cell Carcinoma | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0008626 | Congenital chromosomal disease | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C3539781 | Progressive cGVHD | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C3853548 | Pdgfra-Associated Chronic Eosinophilic Leukemia | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C4054188 | Ph-Like Acute Lymphoblastic Leukemia | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0023473 | Myeloid Leukemia, Chronic | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0024117 | Chronic Obstructive Airway Disease | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0024299 | Lymphoma | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0025286 | Meningioma | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0027765 | nervous system disorder | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0027819 | Neuroblastoma | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0035412 | Rhabdomyosarcoma | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0178874 | Tumor Progression | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0205851 | Germ cell tumor | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0206180 | Ki-1+ Anaplastic Large Cell Lymphoma | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0235974 | Pancreatic carcinoma | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0280100 | solid tumor | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0334579 | Anaplastic astrocytoma | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0346647 | Malignant neoplasm of pancreas | 0.0005494535684262 | BEFREE |
| 5159 | PDGFRB | C0585442 | Osteosarcoma of bone | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0598766 | Leukemogenesis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0677936 | Refractory cancer | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0684249 | Carcinoma of lung | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0686619 | Secondary malignant neoplasm of lymph node | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0699790 | Colon Carcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0699791 | Stomach Carcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0745091 | Hypereosinophilia | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0751690 | Malignant Peripheral Nerve Sheath Tumor | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0795878 | Monosomy 22 | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0812413 | Malignant Pleural Mesothelioma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0836924 | Thrombocytosis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0848332 | Spots on skin | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0860564 | Retinoic acid syndrome | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1096063 | Drug Resistant Epilepsy | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1266121 | Myofibroma (morphologic abnormality) | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1292758 | Precursor T-cell lymphoblastic lymphoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1301355 | Myelodysplastic-Myeloproliferative Diseases | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1306460 | Primary malignant neoplasm of lung | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1540912 | Hypereosinophilic syndrome | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1658953 | tumor vasculature | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1800706 | Idiopathic Pulmonary Fibrosis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0001430 | Adenoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0001815 | Primary Myelofibrosis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1847319 | PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0002871 | Anemia | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1847835 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0004096 | Asthma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0004238 | Atrial Fibrillation | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1852502 | CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1853926 | NONAKA MYOPATHY | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0006287 | Bronchopulmonary Dysplasia | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0007102 | Malignant tumor of colon | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0007103 | Malignant neoplasm of endometrium | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0007113 | Rectal Carcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0007138 | Carcinoma, Transitional Cell | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0008479 | Chondrosarcoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1883486 | Uterine Corpus Cancer | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0008487 | Chordoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C2145472 | Urothelial Carcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0008497 | Choriocarcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0009324 | Ulcerative Colitis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C2827469 | Coronary Microvascular Disease | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C2986703 | Overgrowth Syndrome | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0010346 | Crohn Disease | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0011644 | Scleroderma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C3463824 | MYELODYSPLASTIC SYNDROME | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C3539878 | Triple Negative Breast Neoplasms | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0015230 | Exanthema | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C3711560 | Pdgfrb-Associated Chronic Eosinophilic Leukemia | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0016057 | Fibrosarcoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0017658 | Glomerulonephritis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0022665 | Kidney Neoplasm | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0023449 | Acute lymphocytic leukemia | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0023467 | Leukemia, Myelocytic, Acute | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0023601 | Leydig Cell Tumor | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0024232 | Lymphatic Metastasis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0026499 | Monosomy | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0026650 | Movement Disorders | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0026987 | Myelofibrosis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0027656 | Neoplasms, Connective Tissue | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0027708 | Nephroblastoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0029463 | Osteosarcoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0029925 | Ovarian Carcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0032463 | Polycythemia Vera | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0036421 | Systemic Scleroderma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0038220 | Status Epilepticus | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0039590 | Testicular Neoplasms | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0041341 | Tuberous Sclerosis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0041956 | Ureteral obstruction | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0042900 | Vitiligo | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0079218 | Fibromatosis, Aggressive | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0085786 | Hamman-Rich syndrome | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0149782 | Squamous cell carcinoma of lung | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0149939 | Obstructive nephropathy | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0151650 | Renal fibrosis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0153676 | Secondary malignant neoplasm of lung | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0205699 | Carcinomatosis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0206620 | Lymphangioma, Cystic | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0206651 | Sarcoma, Clear Cell | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0206657 | Alveolar Soft Part Sarcoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0206698 | Cholangiocarcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0220668 | Congenital contractural arachnodactyly | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0238461 | Anaplastic thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0238462 | Medullary carcinoma of thyroid | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0238463 | Papillary thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0241961 | Angiomyolipoma of kidney | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0242379 | Malignant neoplasm of lung | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0263662 | Disseminated eosinophilic collagen disease | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0263746 | Osteoarthritis of the hand | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0268238 | Triglyceride storage disease with ichthyosis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0279626 | Squamous cell carcinoma of esophagus | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0279628 | Adenocarcinoma Of Esophagus | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0280785 | Diffuse Astrocytoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0333463 | Senile Plaques | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0334279 | Adenocarcinoma, intestinal type | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0334280 | Carcinoma, diffuse type | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0334409 | Leydig cell tumor, benign | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0338656 | Impaired cognition | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0340548 | Pulmonary capillary hemangiomatosis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0345904 | Malignant neoplasm of liver | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0349204 | Nonorganic psychosis | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0349566 | Squamous cell carcinoma of tongue | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0349639 | Juvenile Myelomonocytic Leukemia | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0376545 | Hematologic Neoplasms | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0405581 | Testicular dysfunction | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0432412 | Chromosome 8, trisomy | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0476089 | Endometrial Carcinoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0494165 | Secondary malignant neoplasm of liver | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0553580 | Ewings sarcoma | 0.0002747267842131 | BEFREE |
| 5159 | PDGFRB | C0555198 | Malignant Glioma | 0.0002747267842131 | BEFREE |